021-51111890
购物车（）
sales@molnova.cn
p5 Ligand for Dnak and DnaJ
CAS No. 209518-24-1
p5 Ligand for Dnak and DnaJ ( —— )
产品货号. M30195 CAS No. 209518-24-1
p5 Ligand for Dnak and DnaJ is a non-apeptide and correspond to the main binding sites of the 23 residues of the mitochondrial aspartate aminotransferase presequence.P5 ligand is a high affinity ligand for Dnak and DnaJ.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称p5 Ligand for Dnak and DnaJ
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述p5 Ligand for Dnak and DnaJ is a non-apeptide and correspond to the main binding sites of the 23 residues of the mitochondrial aspartate aminotransferase presequence.P5 ligand is a high affinity ligand for Dnak and DnaJ.
-
产品描述p5 Ligand for Dnak and DnaJ is a non-apeptide and correspond to the main binding sites of the 23 residues of the mitochondrial aspartate aminotransferase presequence.P5 ligand is a high affinity ligand for Dnak and DnaJ.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Cytoskeleton/Cell Adhesion Molecules
-
靶点HSP
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number209518-24-1
-
分子量1028.27
-
分子式C44H81N15O11S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:{Cys}{Leu}{Leu}{Leu}{Ser}{Ala}{Pro}{Arg}{Arg}
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Hsp70-derived octape...
A group of tetratricopeptide repeat (TPR)-containing proteins has been shown to interact with the C-terminal domain of the 70 kDa heat-shock cognate protein (hsc70). In the present study, the effect of the TPR-containing proteins, including the C-terminus of hsc70-interacting protein (CHIP), TPR1 and human glutamine-rich TPR-containing protein (hSGT), on refolding of luciferase by DnaJ and hsc70 was investigated.
-
Donepezil
多奈哌齐是一种基于哌啶的、有效的、特异性的、可逆的乙酰胆碱酯酶 (AChE) 抑制剂。
-
PU-H71 HCl
PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT. PU-H71 HCL shows antitumor activity in many preclinical models of malignancy. PU-H71 HCL has an inhibitory effect on the protein expression levels of Rad51 and Ku70, which may be associated with the double chain break repair in the homologous recombination pathway and non-homologous end-joining pathway.
